Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 477-488.e4
Open Access | Times Cited: 814

Showing 26-50 of 814 citing articles:

Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 373
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, et al.
Science (2021) Vol. 373, Iss. 6559, pp. 1109-1116
Open Access | Times Cited: 361
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
Jingwen Ai, Haocheng Zhang, Yi Zhang, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 337-343
Open Access | Times Cited: 361
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 360
SARS-CoV-2 infection in free-ranging white-tailed deer
Vanessa L. Hale, Patricia M. Dennis, Dillon S. McBride, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 481-486
Open Access | Times Cited: 359
The variant gambit: COVID-19’s next move
Jessica A. Plante, Brooke Mitchell, Kenneth S. Plante, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 508-515
Open Access | Times Cited: 347
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A. Pinsky, Mehul S. Suthar, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 664-666
Open Access | Times Cited: 345
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
Jinhui Dong, Seth J. Zost, Allison J. Greaney, et al.
Nature Microbiology (2021) Vol. 6, Iss. 10, pp. 1233-1244
Open Access | Times Cited: 310
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, et al.
Science (2021) Vol. 374, Iss. 6566, pp. 472-478
Open Access | Times Cited: 299
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
Parakkal Deepak, Wooseob Kim, Michael Paley, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 11, pp. 1572-1585
Open Access | Times Cited: 291
Germinal centre-driven maturation of B cell response to mRNA vaccination
Wooseob Kim, Julian Q. Zhou, Stephen Horváth, et al.
Nature (2022) Vol. 604, Iss. 7904, pp. 141-145
Open Access | Times Cited: 288
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Frauke Muecksch, Yiska Weisblum, Christopher O. Barnes, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1853-1868.e7
Open Access | Times Cited: 284
Broad sarbecovirus neutralization by a human monoclonal antibody
M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 103-108
Open Access | Times Cited: 276
Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants
Helena de Puig, Rose Lee, Devora Najjar, et al.
Science Advances (2021) Vol. 7, Iss. 32
Open Access | Times Cited: 256
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen, Emma S. Winkler, James Brett Case, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 103-108
Open Access | Times Cited: 252
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 240
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109415-109415
Open Access | Times Cited: 233
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 220
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin, Alina Baum, Elzbieta Wloga, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3949-3961.e11
Open Access | Times Cited: 213
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
Jie Hu, Pai Peng, Xiaoxia Cao, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 293-295
Open Access | Times Cited: 209
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants
Charlie Laffeber, Kelly de Koning, Roland Kanaar, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 15, pp. 167058-167058
Open Access | Times Cited: 208
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 208
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 206
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 522-528.e2
Open Access | Times Cited: 193

Scroll to top